ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
In its second deal in as many weeks, Patheon has agreed to buy Agere Pharmaceuticals, which specializes in improving the absorption rate, or bioavailability, of drugs. Patheon says Agere’s Bend, Ore., headquarters will become a solubility center of excellence for its pharmaceutical development services operations. Patheon, which last year merged with DSM’s fine chemicals business, is in the process of acquiring the pharmaceutical chemical firm Irix Pharmaceuticals.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X